MEET US AT OUTSOURCING IN CLINICAL TRIALS & CLINICAL TRIAL SUPPLY EAST ASIA 2022

The leading clinical Outsourcing conference in East Asia is returning on 29th-30th Nov 2022. With a focus on providing delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials, this is an event not to be missed. Conference with a specific focus on the East Asian market- Unlike other conferences, the event focuses especially on the regional pharmaceutical business in Asia, highlighting the industry’s current difficulties as well as its exciting innovations and growth prospects.

Bo van den Heuvel, our Manager Data and Study Set Up, Viroclinics Xellerate (a Cerba Research Company), will host a speaking slot:

An APAC focused agile case study on strategizing and executing pandemic proof phase 2/3 trials

Viroclinics Xellerate, A Cerba Research Company, will shed light on the following key topics:

• Pre-requisites of successful agility in outsourced clinical trials – ACCESSIBILITY in its broadest sense
• The importance of end-to-end clinical trial solutions
• Pandemic proof clinical trial agility – necessity and importance of scalable outsourcing & transfer strategies
• Key learnings on how to implement continuous agility in clinical trials
• And more …..

Bo van den Heuvel holds a Bachelor of Science in Biomedical Laboratory Research, specializing in sample logistics, kit building and data management. She started her career at Viroclinics Xellerate, A Cerba Research Company, as laboratory technician and quickly rose through the ranks. Her main experience is in Virology and Immunology clinical trials. In her spare time, she enjoys fitness and tennis and hanging out with friends.

Meet the Team at Booth Nr. 3 !